Physician profile

Virginia Oneil

Physician Assistant · Norwood, MA

NPI 1669471041

$3,766.72

in general payments reported to CMS, 2019-2025

43 companies · $714 in 2025

The $714 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).

See the full distribution for Physician Assistant

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,149.06
Education$363.39

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Astellas Pharma US INC $988.61 2021-2025 Veozah, Xtandi, Myrbetriq
180 Medical, INC. $303.69 2021-2025 Gentlecath, Cure Catheter
Tolmar, INC. $183.03 2023-2025 Eligard
Sumitomo Pharma America, INC. $149.46 2023-2025 Gemtesa
Urovant Sciences INC $143.63 2022
Janssen Biotech, INC. $138.09 2022-2025 Erleada
Ferring Pharmaceuticals INC. $132.15 2024-2025 Adstiladrin
Abbvie INC. $114.00 2022-2024
Pfizer INC. $101.59 2021-2024
Antares Pharma, INC. $99.33 2022-2024 Xyosted, Nocdurna, Tlando
Merck Sharp & Dohme LLC $93.28 2021-2024 Keytruda, Welireg, Lynparza
Immunitybio, INC. $90.83 2024-2025
Endo USA, INC. $88.49 2025 Aveed, Xiaflex
Dendreon Pharmaceuticals LLC $85.28 2021-2025 Provenge
Myriad Genetic Laboratories, INC. $83.31 2023-2025 Prolaris, Myrisk
Show all 43 companies
CompanyGeneral paymentsYearsTop products
Accord Healthcare, INC. $68.69 2025
Endo Pharmaceuticals INC. $67.44 2021-2023 Xiaflex, Aveed
Amgen INC. $62.09 2021-2023 Prolia
Novartis Pharmaceuticals Corporation $59.92 2022-2023
Urogen Pharma, INC. $59.82 2023-2024 Jelmyto
Telix Pharmaceuticals $56.81 2022-2024 Illuccix
Jazz Pharmaceuticals INC. $49.10 2022
Terumo Medical Corporation $45.69 2025 Angio-Seal
Progenics Pharmaceuticals, INC. $45.56 2022-2023 Pylarify
Mission Pharmacal Company $38.64 2022-2023 Uribel
Dentsply Ih INC. $37.66 2021
Hologic Sales and Service, LLC $36.72 2024-2025 Aptima
Coloplast Corp $31.42 2021-2024
Novo Nordisk INC $24.84 2024 Rivfloza
Dentsply Ih Ab $24.63 2023 Lofric
Bioprotect Medical, INC. $24.58 2025 Bioprotect Balloon Implant System
Halozyme INC $24.18 2023
Teleflex LLC $23.62 2024 Urolift
Boston Scientific Corporation $23.44 2025 Solyx Sis System
Otsuka America Pharmaceutical, INC. $23.40 2022
Myovant Sciences INC. $22.12 2022
Abc Home Medical Supply, INC. $20.57 2025
Agiliti Surgical, INC. $20.50 2023 Soltive
Blue Earth Diagnostics $18.89 2023
Calyxo, INC. $17.52 2025 Cvac Aspiration System
Travere Therapeutics, INC. $17.04 2021
Bayer Healthcare Pharmaceuticals INC. $14.17 2021
Genzyme Corporation $12.89 2021

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Virginia Oneil

$3,766.72

in general payments reported 2019-2025

Years
2021-2025
Top company
Astellas Pharma US INC
Context
The $714 reported for 2025 was more than what 78% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10579077/virginia-oneil

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.